Study on anal HPV infection, precancerous lesions incidence, and risk factors in populations with cervical HPV positivity

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500110765

Enrollment

Unknown

Registered

2025-10-20

Start date

2026-01-01

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal cancer and precancerous lesions

Interventions

Trial group:None

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Persistent positivity for high-risk cervical HPV for more than 6 months; (2) Signing the informed consent form.

Exclusion criteria

Exclusion criteria: (1) History of anal precancerous lesions or anal cancer; (2) Pregnancy; (3) Post-total hysterectomy; (4) Subjects without the ability to make autonomous decisions; (5) Current or planned participation in other HPV-related clinical studies.

Design outcomes

Primary

Measure	Time frame
Anal HPV infection rate;	—

Secondary

Measure	Time frame
Anal cytology examination;High-resolution anoscopy;	—

Countries

China

Contacts

Public ContactLong Sui

Fudan University Affiliated Obstetrics and Gynecology Hospital

suilong@fudan.edu.cn+86 138 0178 8118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026